EUVIMEDEUVIMED entdecken
Crossref

Serine protease HTRA1 is a common autoantigen in membranous nephropathy in patients of 80 years and older

Laith F Al-Rabadi, Aaron J Storey, Tamer Abuelsamen, Suguru Takayama, Patrick D Walker, Chinedu E Nwaduru, Issa Kawalit, Michael Zimmerman, Elion Hoxha, Dorin-Bogdan Borza, Laurence Beck, Christopher P Larsen und 1 weitere

Kidney International · 2026-06 · 109 (6) · 1318-1323

DOI: 10.1016/j.kint.2026.02.036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kidney International, 2026-06. Verfasst von Laith F Al-Rabadi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, University of Utah Health, Salt Lake City, Utah, USA. Electronic address: laith.al-rabadi@hsc.utah.edu. Hauptthemen laut MEDLINE: Glomerulonephritis, Membranous, High-Temperature Requirement A Serine Peptidase 1, Autoantigens. Die Arbeit nennt 19 Literaturangaben. Gefördert von: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Membranous nephropathy (MN) in very elderly patients frequently remains antigen-negative after routine testing, limiting diagnostic precision. Recently, serine protease high temperature requirement protein A1 (HTRA1) has been identified as a novel MN autoantigen. Here, we focused on patients 80 years and older with MN and sought to systematically evaluate this association. METHODS Three cohorts of patients with MN were examined under institutional approval, including 157 consecutive all-age series of PLA2R/THSD7A/NELL1/EXT1-negative patients with MN typed by mass spectrometry; 54 PLA2R-negative MN in patients aged 80 years and older assessed by paraffin immunofluorescence; and 45 PLA2R-negative malignancy-associated patients with MN. HTRA1 positivity was determined by paraffin immunofluorescence and/or mass spectrometry. Clinical and histopathologic features were reviewed where available. Proportions were compared using Fisher's exact test. RESULTS HTRA1 positivity was identified in 1.9% of patients with PLA2R/THSD7A/NELL1/EXT-negative MN, 22.2% of patients 80 years and older, and 6.7% of patients with PLA2R-negative malignancy-associated MN. Compared with the all-age antigen-negative cohort, HTRA1 positivity was significantly enriched in patients aged 80 years (relative risk 11.6; 95% confidence interval 3.4- 39.7). Across all 18 HTRA1-positive cases, mean age was 81.5, 66.7% were male, and 83.3% had nephrotic-range proteinuria. CONCLUSIONS HTRA1 is a common autoantigen in PLA2R-negative MN among very elderly patients, occurring in approximately one in five cases aged 80 years or more. These findings support inclusion of HTRA1 testing in diagnostic evaluation of antigen-negative MN in patients 80 years and older and suggest the existence of an age-linked MN subtype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glomerulonephritis, MembranousHigh-Temperature Requirement A Serine Peptidase 1AutoantigensHumansAged, 80 and overMaleFemaleAge FactorsReceptors, Phospholipase A2Biopsy

Stichwörter der Autor:innen

HTRA1antigencase serieskidney biopsymembranous nephropathy

Substanzen

High-Temperature Requirement A Serine Peptidase 1HTRA1 protein, humanAutoantigensReceptors, Phospholipase A2

Autor:innen und Institutionen

  • Division of Nephrology, University of Utah Health, Salt Lake City, Utah, USA. Electronic address: laith.al-rabadi@hsc.utah.edu.
  • Arkana Laboratories, Little Rock, Arkansas, USA.
  • Division of Nephrology, University of Utah Health, Salt Lake City, Utah, USA.
  • International Renal Care Association, Amman, Jordan.
  • Department of Medicine, University Hospital Würzburg, Würzburg, Germany.
  • Department of Microbiology and Immunology, Meharry Medical College, Nashville, Tennessee, USA.

Förderung

  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Al-Rabadi, L. F., Storey, A. J., Abuelsamen, T., Takayama, S., Walker, P. D., Nwaduru, C. E., Kawalit, I., Zimmerman, M., Hoxha, E., Borza, D. B., Beck, L., Larsen, C. P., & Caza, T. N. (2026). Serine protease HTRA1 is a common autoantigen in membranous nephropathy in patients of 80 years and older. Kidney International, 109(6), 1318-1323. https://doi.org/10.1016/j.kint.2026.02.036

Vancouver

Al-Rabadi LF, Storey AJ, Abuelsamen T, Takayama S, Walker PD, Nwaduru CE, et al. Serine protease HTRA1 is a common autoantigen in membranous nephropathy in patients of 80 years and older. Kidney International. 2026;109(6):1318-1323. doi:10.1016/j.kint.2026.02.036

BibTeX
@article{AlRabadi2026,
  author = {Al-Rabadi, Laith F and Storey, Aaron J and Abuelsamen, Tamer and Takayama, Suguru and Walker, Patrick D and Nwaduru, Chinedu E and Kawalit, Issa and Zimmerman, Michael and Hoxha, Elion and Borza, Dorin-Bogdan and Beck, Laurence and Larsen, Christopher P and Caza, Tiffany N},
  title = {Serine protease HTRA1 is a common autoantigen in membranous nephropathy in patients of 80 years and older},
  journal = {Kidney International},
  year = {2026},
  volume = {109},
  number = {6},
  pages = {1318--1323},
  doi = {10.1016/j.kint.2026.02.036}
}
Kostenlos starten →